³Ô¹ÏÍøÕ¾

Latest chemotherapy News | Page 7

Harpist Narelle plays from the heart for Mater cancer patients
Unprecedented collaboration: Prominent Australians unite to combat blood cancer on World Blood Cancer Day?
Imfinzi plus Lynparza and Imfinzi alone both significantly improved progression-free survival in advanced endometrial cancer when added to chemotherapy
Leon’s cancer How he opened up and why other men should too
Unprecedented collaboration: Prominent Australians unite to combat blood cancer on World Blood Cancer Day?
Cancers in distant organs alter liver function
AstraZeneca will highlight momentum of practice-changing cancer medicines across its robust pipeline at ASCO 2023
Australians battling with prostate cancer to benefit from new PBS listing
Four common palliative care myths 23 May
Researchers Modify Drug to Enter Cells and Treat Pain
Positive results for Immutep’s cancer candidate in combination with MSD’s Keytruda
Volunteer Pamela lends ‘healing hands’ to Mater cancer patients
When facing ovarian cancer, Susan Catton saw an opportunity to help others
New treatment promises to increase lung cancer survival
Mater Research leads in palliative care oncology research
Mater Research Celebrates International Nurses Day
Amplia Therapeutics says third cohort enrolment completed in ACCENT clinical trial
Artificial intelligence to predict chemotherapy toxicities in colon cancer patients
Gene Tiam1 orchestrates the development of chronic neuropathic pain
Carina Biotech to present details of planned trial of CAR-T cell therapy candidate
Researcher shares his reason to run in HBF Run for a Reason
10 myths about sun protection
Update on FDA Advisory Committee vote on Lynparza plus abiraterone for metastatic castration-resistant prostate cancer
Blood pressure medication combined with chemotherapy could reduce spread in triple negative breast cancer
WHO releases three online products to support implementation of NTD programmes
AstraZeneca advances its pipeline and highlights progress in immuno-oncology, ADCs, cell therapy and epigenetics at AACR
Delivering Better Care At ³Ô¹ÏÍøÕ¾
Social solution – rare ovarian cancer insights
Lynparza and Imfinzi combination improved progression-free survival in newly diagnosed patients with advanced ovarian cancer without tumour BRCA mutations in DUO-O Phase III trial
Scientists Reveal More about the Process Behind a Recently Discovered Type of Cell Death
Chahla’s Perfect Cancer
Researchers uncover the first steps driving antibiotic resistance
License agreement with KYM Biosciences for CMG901, a Claudin-18.2 antibody drug conjugate, completed
ENZAMET shows promise as prostate cancer treatment
Denise and Graeme’s Love and support throughout their cancer experience
Alex Jalloh remembers bond he had with his twin brother
New combination therapy for advanced prostate cancer secures TGA registration
Immutep announces initiation of new breast cancer trial
Brisbane’s sea of pink sets new fund-raising record
Bringing regional communities closer to specialist care
Running buddies step up for breast cancer survivor Sarah
Clinical Trials striving to improve outcomes for breast cancer patients through cutting edge treatments
Compassionate women in the driver’s seat helping vulnerable patients
Compassionate women in driver’s seat helping patients
Faster genetic tests give hope to ovarian cancer patients
Brave Queensland mum celebrates miracle babies despite ovarian cancer
Update on US regulatory review of Lynparza in combination with abiraterone for metastatic castration-resistant prostate cancer
Engaging childhood brain cancer survivors